Phase 3 Study of Cabozantinib with Nivolumab and Ipilimumab vs Nivolumab and Ipilimumab Alone in Advanced Treatment-Naive Renal Cell Carcinoma


Thank you for your interest in the COSMIC Trials.

Phase 1b study of cabozantinib administered alone or in combination with atezolizumab for solid tumors

Learn More at Clinicaltrials.gov

Phase 3 pivotal trial of cabozantinib in patients with radioiodine-refractory differentiated thyroid cancer who have progressed after prior VEGFR (vascular endothelial growth factor receptor)–targeted therapy

Learn More at Clinicaltrials.gov

Phase 3 study of cabozantinib in combination with atezolizumab compared to sorafenib in advanced treatment-naive HCC (hepatocellular carcinoma)

Learn More at Clinicaltrials.gov

Phase 3 study of cabozantinib with nivolumab and ipilimumab vs nivolumab and ipilimumab alone in advanced treatment-naive RCC (renal cell carcinoma)

Learn More at Clinicaltrials.gov

USES DESCRIBED HERE ARE INVESTIGATIONAL.

SAFETY AND EFFICACY HAVE NOT BEEN ESTABLISHED.